[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT TYR-561.
TISSUE=Placenta;
DOI=10.1016/0092-8674(94)90235-6; PubMed=7512451 [NCBI, ExPASy, EBI, Israel, Japan]
Akira S.,
Nishio Y.,
Inoue M.,
Wang X.-J.,
Wei S.,
Matsusaka T.,
Yoshida K.,
Sudo T.,
Naruto M.,
Kishimoto T.;
"Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.";
Cell 77:63-71(1994).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
DOI=10.1016/S0378-1119(98)00185-1; PubMed=9630560 [NCBI, ExPASy, EBI, Israel, Japan]
Della Pietra L.,
Bressan A.,
Pezzotti A.,
Serlupi-Crescenzi O.;
"Highly conserved amino-acid sequence between murine STAT3 and a revised human STAT3 sequence.";
Gene 213:119-124(1998).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ILE-143.
SeattleSNPs variation discovery resource;
Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND DEL-701).
TISSUE=Kidney, and Pancreas;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 564-704.
TISSUE=Liver;
Della Pietra L.,
Bressan A.,
Pezzotti A.R.,
Serlupi-Crescenzi O.;
Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
PHOSPHORYLATION AT SERINE RESIDUES.
DOI=10.1126/science.7701321; PubMed=7701321 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang X.,
Blenis J.,
Li H.-C.,
Schindler C.,
Chen-Kiang S.;
"Requirement of serine phosphorylation for formation of STAT-promoter complexes.";
Science 267:1990-1994(1995).
|
[7]
|
INTERACTION WITH NCOA1.
DOI=10.1074/jbc.M111486200; PubMed=11773079 [NCBI, ExPASy, EBI, Israel, Japan]
Giraud S.,
Bienvenu F.,
Avril S.,
Gascan H.,
Heery D.M.,
Coqueret O.;
"Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a.";
J. Biol. Chem. 277:8004-8011(2002).
|
[8]
|
INTERACTION WITH HCV CORE PROTEIN.
DOI=10.1084/jem.20012127; PubMed=12208879 [NCBI, ExPASy, EBI, Israel, Japan]
Yoshida T.,
Hanada T.,
Tokuhisa T.,
Kosai K.,
Sata M.,
Kohara M.,
Yoshimura A.;
"Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation.";
J. Exp. Med. 196:641-653(2002).
|
[9]
|
INTERACTION WITH IL23R.
PubMed=12023369 [NCBI, ExPASy, EBI, Israel, Japan]
Parham C.,
Chirica M.,
Timans J.,
Vaisberg E.,
Travis M.,
Cheung J.,
Pflanz S.,
Zhang R.,
Singh K.P.,
Vega F.,
To W.,
Wagner J.,
O'Farrell A.-M.,
McClanahan T.K.,
Zurawski S.,
Hannum C.,
Gorman D.,
Rennick D.M.,
Kastelein R.A.,
de Waal Malefyt R.,
Moore K.W.;
"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.";
J. Immunol. 168:5699-5708(2002).
|
[10]
|
FUNCTION, AND INTERACTION WITH IL31RA.
DOI=10.1074/jbc.M401122200; PubMed=15194700 [NCBI, ExPASy, EBI, Israel, Japan]
Dreuw A.,
Radtke S.,
Pflanz S.,
Lippok B.E.,
Heinrich P.C.,
Hermanns H.M.;
"Characterization of the signaling capacities of the novel gp130-like cytokine receptor.";
J. Biol. Chem. 279:36112-36120(2004).
|
[11]
|
INTERACTION WITH TMF1.
DOI=10.1038/sj.onc.1208149; PubMed=15467733 [NCBI, ExPASy, EBI, Israel, Japan]
Perry E.,
Tsruya R.,
Levitsky P.,
Pomp O.,
Taller M.,
Weisberg S.,
Parris W.,
Kulkarni S.,
Malovani H.,
Pawson T.,
Shpungin S.,
Nir U.;
"TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3.";
Oncogene 23:8908-8919(2004).
|
[12]
|
INTERACTION WITH PELP1.
DOI=10.1158/0008-5472.CAN-04-4664; PubMed=15994929 [NCBI, ExPASy, EBI, Israel, Japan]
Manavathi B.,
Nair S.S.,
Wang R.-A.,
Kumar R.,
Vadlamudi R.K.;
"Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.";
Cancer Res. 65:5571-5577(2005).
|
[13]
|
INTERACTION WITH SOCS7.
DOI=10.1074/jbc.M411596200; PubMed=15677474 [NCBI, ExPASy, EBI, Israel, Japan]
Martens N.,
Uzan G.,
Wery M.,
Hooghe R.,
Hooghe-Peters E.L.,
Gertler A.;
"Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation.";
J. Biol. Chem. 280:13817-13823(2005).
|
[14]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1074/mcp.M500089-MCP200; PubMed=15951569 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang Y.,
Wolf-Yadlin A.,
Ross P.L.,
Pappin D.J.,
Rush J.,
Lauffenburger D.A.,
White F.M.;
"Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.";
Mol. Cell. Proteomics 4:1240-1250(2005).
|
[15]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASS SPECTROMETRY.
DOI=10.1038/nbt1046; PubMed=15592455 [NCBI, ExPASy, EBI, Israel, Japan]
Rush J.,
Moritz A.,
Lee K.A.,
Guo A.,
Goss V.L.,
Spek E.J.,
Zhang H.,
Zha X.-M.,
Polakiewicz R.D.,
Comb M.J.;
"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
Nat. Biotechnol. 23:94-101(2005).
|
[16]
|
SUBCELLULAR LOCATION.
DOI=10.1073/pnas.0501643102; PubMed=15919823 [NCBI, ExPASy, EBI, Israel, Japan]
Liu L.,
McBride K.M.,
Reich N.C.;
"STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3.";
Proc. Natl. Acad. Sci. U.S.A. 102:8150-8155(2005).
|
[17]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K.,
Guo A.,
Zeng Q.,
Possemato A.,
Yu J.,
Haack H.,
Nardone J.,
Lee K.,
Reeves C.,
Li Y.,
Hu Y.,
Tan Z.,
Stokes M.,
Sullivan L.,
Mitchell J.,
Wetzel R.,
Macneill J.,
Ren J.M.,
Yuan J.,
Bakalarski C.E.,
Villen J.,
Kornhauser J.M.,
Smith B.,
Li D.,
Zhou X.,
Gygi S.P.,
Gu T.-L.,
Polakiewicz R.D.,
Rush J.,
Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
|
[18]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691, AND MASS SPECTROMETRY.
DOI=10.1126/science.1140321; PubMed=17525332 [NCBI, ExPASy, EBI, Israel, Japan]
Matsuoka S.,
Ballif B.A.,
Smogorzewska A.,
McDonald E.R. III,
Hurov K.E.,
Luo J.,
Bakalarski C.E.,
Zhao Z.,
Solimini N.,
Lerenthal Y.,
Shiloh Y.,
Gygi S.P.,
Elledge S.J.;
"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.";
Science 316:1160-1166(2007).
|
[19]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-714 AND SER-727, AND MASS SPECTROMETRY.
DOI=10.1016/j.molcel.2008.07.007; PubMed=18691976 [NCBI, ExPASy, EBI, Israel, Japan]
Daub H.,
Olsen J.V.,
Bairlein M.,
Gnad F.,
Oppermann F.S.,
Korner R.,
Greff Z.,
Keri G.,
Stemmann O.,
Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
|
[20]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-714 AND SER-727, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N.,
Zhou C.,
Villen J.,
Beausoleil S.A.,
Bakalarski C.E.,
Elledge S.J.,
Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
|
[21]
|
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J.,
Superti-Furga G.,
Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
|
[22]
|
VARIANTS AD-HIES GLN-382; LEU-382; TRP-382; LEU-384; SER-384; GLN-423; VAL-463 DEL; ASN-611; VAL-621; ILE-622; LEU-637; MET-637; GLN-644 DEL AND CYS-657.
DOI=10.1056/NEJMoa073687; PubMed=17881745 [NCBI, ExPASy, EBI, Israel, Japan]
Holland S.M.,
DeLeo F.R.,
Elloumi H.Z.,
Hsu A.P.,
Uzel G.,
Brodsky N.,
Freeman A.F.,
Demidowich A.,
Davis J.,
Turner M.L.,
Anderson V.L.,
Darnell D.N.,
Welch P.A.,
Kuhns D.B.,
Frucht D.M.,
Malech H.L.,
Gallin J.I.,
Kobayashi S.D.,
Whitney A.R.,
Voyich J.M.,
Musser J.M.,
Woellner C.,
Schaffer A.A.,
Puck J.M.,
Grimbacher B.;
"STAT3 mutations in the hyper-IgE syndrome.";
N. Engl. J. Med. 357:1608-1619(2007).
|
[23]
|
VARIANTS AD-HIES GLN-382; TRP-382; ILE-389; TYR-437 AND VAL-463 DEL, AND CHARACTERIZATION OF VARIANTS AD-HIES GLN-382; TRP-382; ILE-389; TYR-437 AND VAL-463 DEL.
DOI=10.1038/nature06096; PubMed=17676033 [NCBI, ExPASy, EBI, Israel, Japan]
Minegishi Y.,
Saito M.,
Tsuchiya S.,
Tsuge I.,
Takada H.,
Hara T.,
Kawamura N.,
Ariga T.,
Pasic S.,
Stojkovic O.,
Metin A.,
Karasuyama H.;
"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.";
Nature 448:1058-1062(2007).
|
|